AQR Arbitrage’s Day One Biopharmaceuticals DAWN Stock Holding History

AQR Arbitrage’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,462,154	Closed	-$52.8M	–	646
2026 Q1	$52.8M	Buy	+2,462,154	New	+$34.7M	0.87%	32

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Arbitrage's DAWN Position: Q2 2026 in Review

AQR Arbitrage sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 2,462,154 shares — an estimated $52.8M sold.

AQR Arbitrage first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $52.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

AQR Arbitrage reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
AQR Arbitrage sold 2,462,154 Day One Biopharmaceuticals shares in Q2 2026, an estimated $52.8M.
AQR Arbitrage first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
AQR Arbitrage's Day One Biopharmaceuticals position peaked at $52.8M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.